Sector Update: Health Care

By
A A A

Health-care shares were generally lower in pre-market trading Thursday.

Tekmira Pharmaceuticals (TKMR, TKM.TO) said it has received a $1.5 million milestone payment from Monsanto ( MON ) following the completion of specified program developments. The developer of RNA interference therapeutics said the development milestone is part of the research program under the agreement Tekmira signed with Monsanto in January. The potential value of the transaction could reach $86.2 million, following the successful completion of all program milestones. TKMR was inactive in recent pre-market trading after closing Wednesday at $10.59, in the lower half of its 52-week range between $4.81 and $31.48.

Regado Biosciences ( RGDO ), a biopharmaceutical company, reported Thursday the United States Food and Drug Administration placed a clinical hold on all patient enrollment and dosing in the ongoing Phase 3 REGULATE-PCI trial. According to the FDA, the move was intended to formalize the involvement of the FDA in any decision to re-initiate enrollment and dosing in the future. RGDO tumbled 7.4% pre-market to $2.50, nearing its 52-week low of $2.61.



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


This article appears in: Investing , Commodities

Referenced Stocks: MON , RGDO

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos

The Pumpkin Carvers
The Pumpkin Carvers                 

Stocks

Referenced

75%
100%

Most Active by Volume

71,056,961
  • $97.612 ▲ 3.05%
40,884,735
  • $70.92 ▲ 2.38%
40,788,181
  • $45.0701 ▲ 0.54%
34,758,673
  • $15.535 ▲ 0.10%
29,150,756
  • $22.475 ▼ 9.45%
28,380,754
  • $10.95 ▲ 11.17%
27,937,501
  • $28.70 ▲ 0.63%
27,162,293
  • $3.445 ▼ 1.01%
As of 7/23/2014, 02:13 PM